Fact CheckerSign in

NCT06516237Recruiting

Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis

Relationships Between Intestinal Ultrasound Parameters and Elastography Measurements With Histopathologic Findings in a Prospective Cohort of Patients With Ulcerative Colitis: Development of Novel Imaging and Molecular Biomarkers of Fibrosis

Source: ClinicalTrials.gov · Last updated 15 Jan 2026

Brief summary (registry, in English)

Prospective multicenter interventional non-randomized cross-sectional study. Ultrasound operators will be blinded to clinical and endoscopic findings and the endoscopist will be blinded of the clinical and ultrasound findings. This study aims to develop novel imaging and molecular biomarkers of fibrosis, through the use of intestinal ultrasound and shear wave elastography, using histologic specimens obtained by endoscopic biopsies as reference standard.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
10 Jun 2024
Start date
21 Nov 2024
Primary completion date
31 Jul 2026
Lead sponsor
IRCCS San Raffaele
NCT number
NCT06516237

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 21 Nov 2024 to the primary completion date, 31 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • subjects who needs to change therapy

Other illness

  • presence of ascites, active infections, any contraindication to colonoscopy (e.g. intolerance to preparation, severe flare),
  • poor quality of ultrasound imaging (due to luminal gas or body habitus), or a diagnosis of malignancy in the pathological specimen.

Other

  • Pregnancy,
  • inability to undergo intestinal ultrasound within the time set by the study,

Who the study is looking for

  • Adult, 18 years of age and older,
  • Established diagnosis (\> three months) of ulcerative colitis,
  • Performing colonoscopy, according to current standards of care and ECCO guidelines,
  • Ability to understand and comply with the study procedure and sign an informed consent form

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS San Raffaele Hospital, Milano
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.